Anqa Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Anqa Management’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,815	Closed	-$59K	–	25
2022 Q3	$59K	Hold	5,815	–	–	0.06%	26
2022 Q2	$57K	Hold	5,815	–	–	0.06%	27
2022 Q1	$58K	Hold	5,815	–	–	0.07%	24
2021 Q4	$58K	Hold	5,815	–	–	0.07%	22
2021 Q3	$58K	Hold	5,815	–	–	0.06%	22
2021 Q2	$58K	Hold	5,815	–	–	0.06%	22
2021 Q1	$59K	Buy	+5,815	New	+$62K	0.07%	23

Anqa Management's FLACU Position: Q4 2022 in Review

Anqa Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2022, closing a stake of 5,815 shares — an estimated $59K sold.

Anqa Management first reported a position in FLACU in Q1 2021 and held it in 7 quarters. The position peaked at $59K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACU as of Q4 2022.

Anqa Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
Anqa Management sold 5,815 Frazier Lifesciences Acquisition Corporation Unit shares in Q4 2022, an estimated $59K.
Anqa Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q1 2021 and held it in 7 quarters.
Anqa Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $59K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2022.

Based on Anqa Management's 13F filing for Q4 2022, filed 13 Feb 2023.